Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

NCT00736242 · clinicaltrials.gov ↗

COMPLETED

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C
Hepatitis C
HIV Infections

Interventions

BIOLOGICAL: PEG-IFN alfa-2b
DRUG: RBV

Sponsor

Merck Sharp & Dohme LLC